DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Early Phase II Trials for Cocaine Medication Development - 1

Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders; Substance-Related Disorders

Intervention: Risperidone (Drug)

Phase: Phase 2

Status: Active, not recruiting

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Edward Nunes, M.D., Principal Investigator, Affiliation: Research Foundation for Mental Hygiene

Summary

The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents.

Clinical Details

Official title: Early Phase II Trials for Cocaine Medication Development

Study design: Treatment

Primary outcome:

Side effects

Craving

Drug use

Retention

Eligibility

Minimum age: 18 Years. Maximum age: 60 Years. Gender(s): Both.

Criteria:

Please contact site for information.

Locations and Contacts

Research Foundation for Mental Hygiene, New York, New York 10032, United States
Additional Information

Starting date: June 1994
Last updated: June 23, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014